CALA Research and Charts

CALA - Calithera Biosciences Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-07-02 (Delayed quote data 2025-01-02)

Last 0.00	Change ⇓ 0.00 (0.00%)	Volume 10,659
	Open 0.00	High 0.00	Low 0.00

8EMA (Daily) 0.00	40EMA (Daily) 0.00	50EMA (Daily) 0.00	STO (Daily) 0.000	MACD Hist (Daily) 0.000
8EMA (Weekly) 0.003	40EMA (Weekly) 0.05	50EMA (Weekly) 0.15	STO (Weekly) 0.000	MACD Hist (Weekly) 0.008


Company Profile
Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm is functioned through the region of US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.